InvestorsHub Logo

frrol

05/12/20 6:33 PM

#250444 RE: falconer66a #250437

Or at least reduces the mouse model symptoms. Would be interesting.

bas2020

05/12/20 11:34 PM

#250465 RE: falconer66a #250437

It all fits nicely together.

McMagyar

05/13/20 12:02 AM

#250467 RE: falconer66a #250437

Awesome falconer..
another arrow hits the target

Steady_T

05/13/20 12:37 AM

#250479 RE: falconer66a #250437

Oh Damn, Did Anavex get it right?

jimmy_mcyoloswag

05/13/20 1:57 AM

#250483 RE: falconer66a #250437

*chefs kiss* mwah!

Investor2014

05/13/20 2:11 AM

#250484 RE: falconer66a #250437

Certainly lends support to the proposed Anavex A2-73 Calcium Homeostasis MOA!

Pipilongstocking

05/13/20 9:07 AM

#250502 RE: falconer66a #250437

Thanks for this post!

Lima4918

05/13/20 9:46 AM

#250518 RE: falconer66a #250437

Falconer,

This is amazingly good, and more support for Anavex's MOA. Thank you.

"Their work suggests targeting calcium entry to the mitochondria could be a promising new therapeutic approach in Alzheimer’s disease."


Yes. This is Anavex.